28 results
6-K
EX-99.1
GMAB
Genmab
10 Mar 20
Genmab Announces Appointment of Anthony Mancini to Newly Created Position of Chief Operating Officer
9:17am
truly differentiated new cancer treatments to the market that will deliver on our commitment to improve patients’ lives while fostering a culture
6-K
EX-99.1
GMAB
Genmab
23 Feb 21
Genmab 2020 Annual Report
12:38pm
Exhibit 99.1(a)
Delivering on Our Commitment 2020 Annual Report Genmab A/S CVR No. 21 02 38 84
Table of Contents Management’s Review Financial … Forward Looking Statement Contact Information 71 Environmental, Social, and Governance Commitment to Building a Sustainable and Socially Responsible
6-K
EX-99.1
GMAB
Genmab
23 Feb 21
Genmab 2020 Annual Report
12:38pm
Pipeline
Antibody Technologies
Risk Management
Financial Review
Shareholders and Share Information
Environmental, Social, and Governance
Commitment … continued commitment to oncology has given us purpose and a drive to improve the lives of patients with cancer. We strive to achieve this goal by working
6-K
EX-99.1
GMAB
Genmab
16 Feb 22
Genmab 2021 Annual Report
11:29am
in 1999, our continued commitment to improving patients’ lives has given us purpose and drive as we focus on the creation and development … inspiring team members who are dedicated to bringing our core values and culture to life.
COMMITMENT TO CORPORATE GOVERNANCE, SUSTAINABILITY
6-K
EX-99.1
GMAB
Genmab
16 Feb 22
Genmab 2021 Annual Report
11:29am
of accomplishments rooted in science: From our start in Copenhagen in 1999, our continued commitment to improving patients’ lives has given us purpose and drive … possible without our inspiring team members who are dedicated to bringing our core values and culture to life. Commitment to Corporate Governance
6-K
EX-99.1
61kh6ihixsrajdx27nr
25 Sep 23
Current report (foreign)
8:53am
6-K
EX-99.1
plub0n5vx54rdk316
14 Feb 24
Genmab 2023 Annual Report
12:30pm
6-K
EX-99.1
ftl t2tck
19 Feb 20
Innovating antibodies, improving lives Annual Report 2019 Genmab A/S CVR No. 21 02 38 84
1:28pm
6-K
EX-99.1
7ychur07s75y2x
14 Feb 24
Genmab 2023 Annual Report
12:30pm
6-K
EX-99.1
8uy 7nxflp9
27 Feb 20
Notice to Convene the Annual General Meeting of Genmab A/S
3:48pm
6-K
EX-99.1
mqk59cge
2 May 24
Genmab Announces Financial Results for the First Quarter of 2024
11:08am
6-K
EX-99.1
c6t0tplic
15 Feb 24
Notice to Convene the Annual General Meeting of Genmab A/S
7:23pm
6-K
EX-99.1
qktejq
9 Mar 21
Notice to Convene the Annual General Meeting of Genmab A/S
9:25am
20-F
4w0cp724im5 mus5wtc
30 Mar 20
Annual report (foreign)
5:12pm
DRS/A
EX-10.5
usotjgz
2 Apr 19
Draft registration statement (amended)
12:00am
F-1
EX-10.5
klzcm 3l3
28 May 19
Registration statement (foreign)
4:27pm
DRS/A
0giimoncw8gd9 otnkla
13 May 19
Draft registration statement (amended)
12:00am
F-1/A
1w8i7va2ix
16 Jul 19
Registration statement (foreign) (amended)
8:05am